VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 11 filers reported holding VALLON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $40,000 | -68.5% | 21,250 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $127,000 | -17.5% | 21,250 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $154,000 | +65.6% | 21,250 | +24.3% | 0.00% | +33.3% |
| Q2 2021 | $93,000 | +17.7% | 17,099 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $79,000 | – | 17,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 198,085 | $1,184,000 | 0.18% |
| Laidlaw Wealth Management LLC | 20,200 | $121,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 15,000 | $90,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 21,250 | $127,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,533 | $33,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 14 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,841 | $106,000 | 0.00% |
| STATE STREET CORP | 11,200 | $67,000 | 0.00% |
| MORGAN STANLEY | 2,628 | $16,000 | 0.00% |